Confluence Life Sciences, Inc. — Form D
Confluence Life Sciences, Inc. of SAINT LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2012-07-11. $895K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2012-07-11
- Form: D
- Accession: 0001540502-12-000003
- Industry: Other Health Care
- Exemptions: 06
- Amount sold: $895K
- Minimum investment: $5K
- Investors: 14
- Security types: debt
- Revenue range: Decline to Disclose
Issuer
- Name: Confluence Life Sciences, Inc.
- CIK: 0001540502
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 4320 FOREST PARK AVE., SAINT LOUIS, MO, 63108
- Phone: 314-932-4032
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Dan Broderick | Director | St. Louis, MO |
| Michael Kuo | Director | St. Louis, MO |
| Robert Beardsley | Executive Officer | St. Louis, MO |
| Joseph Monahan | Director | St. Louis, MO |
| Joseph Monahan | Executive Officer | St. Louis, MO |
| Kyparissia Sirinakis | Director | Charlottesville, VA |
| Charles Bolten | Director | St. Louis, MO |
| Walter Smith | Director | St. Louis, MO |
| Walter Smith | Executive Officer | St. Louis, MO |
| Daniel Janiak | Director | St. Louis, MO |
| Jennifer Bohnert | Executive Officer | St. Louis, MO |
| Thomas Smart | Director | St. Louis, MO |
Other filings by this issuer (1)
More